M. Bridget Duffy, MD, is the Chief Medical Officer (CMO) of Vocera Communications, Inc., which provides integrated, intelligent communication that address critical communication challenges within healthcare and other mission-critical industries.Prior to her appointment as CMO at Vocera, Dr. Duffy co-founded and served as Chief Executive Officer of ExperiaHealth, a company whose mission is to assist organizations in rapidly improving staff and patient loyalty through innovative technologies and solutions that restore the human connection in healthcare. ExperiaHealth was acquired by Vocera Communications and now drives the company’s thought leadership and research collaborative as the Experience Innovation Network.Dr. Duffy was an early pioneer in the creation of hospitalist medicine and launched programs to accelerate clinical discovery in the field of Integrative and Heart-Brain medicine, helping establish the Earl and Doris Bakken Heart Brain Institute. She previously served as Chief Experience Officer (CXO) of the Cleveland Clinic – the first senior position of its kind in the nation – leading the institution in improving patient experience as its top strategic priority. She is a frequent speaker on the subject of why patient experience matters and how it impacts clinical outcomes.Her work has earned her the Quantum Leap Award for taking the risk to spur internal change in the field of medicine, and she was featured in HealthLeaders magazine as one of “20 People Who Make Healthcare Better.” In 2014, Dr. Duffy was named one of the “Top 50 in Digital Healthcare” by Rock Health, is a full-service seed fund that supports startups building the next generation of technologies to transform healthcare.Dr. Duffy attended medical school at the University of Minnesota, and completed her residency in internal medicine at Abbott Northwestern Hospital in Minneapolis, MN. She currently serves on the advisory board for Creative Vascular and is a member of the board of directors for Essia Health and Children’s HeartLink.
For more information about